Imara Inc (IMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMRA | CLLS | PRQR | ||
| Company | Imara Inc | Cellectis S.A. ADR | Proqr Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.21 | 2.89 | 2.0000 | ||
| High | 6.32 | 2.99 | 2.0308 | ||
| Low | 5.18 | 2.89 | 2.0000 | ||
| Last | 6.32 | 2.90 | 2.0000 | ||
| Change | +0.87 | -0.09 | +0.0100 | ||
| % Change | +15.96% | -3.01% | +0.50% | ||
| Volume | 271,700 | 1,491 | 5,538 | ||
| 20-Day Average Volume | 97,720 | 51,640 | 161,602 | ||
| Previous Close | 5.45 | 2.99 | 1.9900 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.08 | 2.63 | 2.0468 | ||
| 20-Day Raw Stochastic | 100.00% | 84.52% | 33.97% | ||
| 20-Day Relative Strength | 71.57% | 58.63% | 47.71% | ||
| Weighted Alpha | +131.70 | -32.16 | +2.66 | ||
| Today's Opinion | 100% Buy | 72% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 72% Buy | 8% Buy | ||
| Last Month's Opinion | 96% Buy | 32% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.69% since 02/15/23 | +15.74% since 04/26/24 | +4.68% since 04/26/24 | ||
| Low | 4.45 on 02/22/23 | 2.37 on 04/29/24 | 1.8500 on 05/01/24 | ||
| High | 6.32 on 02/23/23 | 3.01 on 05/02/24 | 2.0500 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | +48.71% since 01/23/23 | +3.94% since 04/03/24 | -4.43% since 04/03/24 | ||
| Low | 3.90 on 01/30/23 | 2.30 on 04/18/24 | 1.8100 on 04/18/24 | ||
| High | 6.32 on 02/23/23 | 3.01 on 05/02/24 | 2.4600 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | +41.70% since 11/23/22 | -1.69% since 02/02/24 | -4.66% since 02/02/24 | ||
| Low | 3.63 on 12/07/22 | 2.30 on 04/18/24 | 1.8100 on 04/18/24 | ||
| High | 6.32 on 02/23/23 | 3.13 on 02/08/24 | 2.7000 on 03/15/24 | ||
| 6-Month | |||||
| %Chg | +459.29% since 08/23/22 | +1.40% since 11/03/23 | +67.83% since 11/03/23 | ||
| Low | 1.10 on 09/01/22 | 2.30 on 04/18/24 | 1.1800 on 11/27/23 | ||
| High | 6.32 on 02/23/23 | 3.77 on 12/20/23 | 3.2900 on 01/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 165,799 | 166,196 | 161,896 | ||
| Shares Outstanding, K | 26,234 | 55,584 | 81,355 | ||
| Annual Sales | 0 | 25,730,000 | 7,050,000 | ||
| Annual Net Income | 1,490,000 | -106,140,000 | -30,430,000 | ||
| Last Quarter Sales | 0 | 1,640,000 | 3,540,000 | ||
| Last Quarter Net Income | 32,190,000 | -17,480,000 | -5,920,000 | ||
| 60-Month Beta | 1.09 | 3.08 | 0.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.23 on 02/10/23 | -0.64 on 04/29/24 | -0.08 on 03/13/24 | ||
| Latest Earnings Date | 03/21/23 | 05/02/24 | 05/21/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 109.00 | 0.00 | 0.00 | ||